Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
PBM Capital Group is a healthcare-focused investment firm founded in 2010 by Paul Manning. The firm is headquartered in Charlottesville, Virginia, with an additional office located in New York City. PBM Capital specializes in investing in companies within the pharmaceutical and life sciences sectors, partnering with scientists, engineers, and entrepreneurs to develop innovative technologies aimed at improving and saving lives. Since its inception, PBM and its portfolio companies have generated over $10 billion in shareholder value.
The firm has a strong track record of successful investments, particularly in the biotech and healthcare industries. Notable milestones include the successful exits of several portfolio companies through acquisitions and initial public offerings (IPOs). PBM Capital's approach combines financial investment with operational support, ensuring that portfolio companies have the resources and expertise needed to thrive in a competitive market.
PBM Capital Group invests primarily in the pharmaceutical and life sciences sectors, focusing on companies that are led by entrepreneurs whose goals align with its investment thesis. The firm emphasizes the importance of operational capabilities and expertise, which it believes are crucial for helping portfolio companies develop revolutionary products. PBM Capital seeks to partner with exceptional scientists, engineers, and entrepreneurs who are dedicated to creating game-changing pharmaceutical and biological technologies.
The firm typically invests in early to growth-stage companies, providing not only capital but also strategic resources and operational support. This hands-on approach allows PBM Capital to play an active role in the development of its portfolio companies, enhancing their potential for success. The firm’s geographic focus is primarily on North America, where it identifies and supports innovative healthcare solutions that address unmet medical needs.
PBM Capital Group has a diverse portfolio of 13 companies, primarily in the biotech and healthcare sectors. Notable portfolio companies include:
In addition to these active investments, PBM Capital has a history of successful exits, including the aforementioned companies, which have significantly contributed to the firm’s reputation and financial success.
Paul B. Manning: Chairman and CEO. Paul previously founded PBM Products, a private label infant formula company, which he grew to become the leading provider in its sector before selling it to Perrigo for $800 million.
Sean Stalfort: President. Sean brings extensive experience in venture capital and operational management, focusing on strategic growth initiatives within the firm.
Jayson Rieger: Managing Partner. Jayson has a strong background in healthcare investments and has led numerous successful funding rounds for portfolio companies.
Dave Zawitz: General Counsel. Dave oversees legal matters and compliance, ensuring that the firm operates within regulatory frameworks.
Joe Pedersen: Partner. Joe specializes in identifying and evaluating new investment opportunities in the biotech sector.
Steven Goldman: Managing Partner. Steven has a wealth of experience in operational support and strategic planning for healthcare startups.
To pitch PBM Capital Group, founders should send an email to info@pbmcap.com. It is recommended to include a comprehensive deck that outlines the business model, team, technology, and market opportunity. Founders should expect a response within a few weeks, depending on the volume of inquiries.
Warm introductions are preferred, as they can facilitate a more favorable review of the pitch. Clear and concise communication about the startup's vision and potential impact in the healthcare sector is crucial for capturing the firm's interest.
In recent months, PBM Capital Group has continued to strengthen its portfolio with strategic investments in the biotech sector. The firm has actively supported its existing companies, including AveXis, Dova Pharmaceuticals, and Verrica Pharmaceuticals, which have all achieved significant milestones such as IPOs and acquisitions.
As of October 2023, PBM Capital remains focused on expanding its influence in the healthcare market, leveraging its operational expertise to drive growth and innovation among its portfolio companies.
What are PBM Capital Group's investment criteria?
PBM Capital Group focuses on investing in the pharmaceutical and life sciences sectors. The firm seeks to partner with companies led by entrepreneurs whose aspirations align with its investment thesis, emphasizing operational capabilities and expertise.
How can startups apply or pitch to PBM Capital Group?
Startups interested in pitching to PBM Capital can reach out via email at info@pbmcap.com. It is advisable to include a detailed business plan and information about the team and technology.
What makes PBM Capital Group different from other venture capital firms?
PBM Capital Group distinguishes itself through its focus on operational expertise and hands-on support for portfolio companies. The firm actively engages with its investments to help them develop revolutionary products that address unmet medical needs.
What is the geographic scope of PBM Capital Group's investments?
The firm primarily invests in North America, focusing on innovative healthcare solutions that can make a significant impact in the pharmaceutical and life sciences sectors.
What is the typical fund size or check size for investments?
While specific fund sizes and check sizes are not publicly disclosed, PBM Capital operates several platform operating companies simultaneously, indicating a capacity for substantial investments in its portfolio companies.
What kind of post-investment involvement does PBM Capital Group have?
PBM Capital Group takes an active role in the development of its portfolio companies, providing operational support and strategic resources to enhance their growth and success in the market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.